Walmart

View Complaint Frequently Asked Questions info@portnoylaw.com It is alleged in the complaint that Walmart made misleading and false statements to the market. Walmart knowingly filled improper prescriptions that were written by “pill-mill” prescribers. Thousands of these prescriptions filled by Walmart demonstrated obvious red flags such as harmful mixtures of medications. Walmart management pressured its pharmacists...

0January 21, 2021January 21, 2021

Lizhi

View Complaint Frequently Asked Questions info@portnoylaw.com According to the lawsuit, the Registration Statement contained misleading and/or false statements and/or failed to disclose that: (1) the coronavirus was already ravaging China, the home base, principal market, and significant hub for Lizhi, its employees, and its customers, at the time of the IPO, ; (2) Lizhi’s business...

0January 21, 2021January 21, 2021

Exxon

View Complaint Frequently Asked Questions info@portnoylaw.com The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Exxon is the subject of a Wall Street Journal article published on January 15, 2021, titled, "Exxon Draws SEC Probe Over Permian Basin Asset Valuation." According to the article, the SEC...

0January 21, 2021January 21, 2021

CleanSpark

View Complaint Frequently Asked Questions info@portnoylaw.com The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors concerning whether the Company fabricated key elements of its business. On January 14, 2021, Culper Research published a report titled "Cleanspark (CLSK): Back to the Trash Can," alleging, among...

0January 19, 2021January 19, 2021

Magnite

View Complaint Frequently Asked Questions info@portnoylaw.com The investigation focuses on whether Magnite issued misleading and/or false statements and/or failed to disclose information pertinent to investors. Magnite is the subject of a research report released by Spruce Point Management on January 7, 2021. It is alleged in this Spruce Point Management report that before its merger...

0January 14, 2021January 14, 2021

CD Projekt

View Complaint Frequently Asked Questions info@portnoylaw.com It is alleged in the complaint that CD misled investors about the fact that Cyberpunk 2077, its highly anticipated videogame, was virtually unplayable on the current-generation PlayStation or Xbox systems, due to an overwhelming amount of bugs, and it was thus reasonably foreseeable that Cyberpunk 2077 would be removed...

0January 12, 2021January 12, 2021

Qiwi

View Complaint Frequently Asked Questions info@portnoylaw.com It is alleged in this complaint that Qiwi made misleading and/or false statements and/or failed to disclose that Qiwi’s internal controls pertaining to record-keeping and reporting were ineffective, and that, consequently, a monetary fine upon the Qiwi would be imposed by the Central Bank of Russia and restrictions would...

0January 12, 2021January 12, 2021

Sarepta

View Complaint Frequently Asked Questions info@portnoylaw.com The investigation focuses on whether Sarepta issued misleading and/or false statements and/or failed to disclose information pertinent to investors. On January 7, 2021, it was announced by Sarepta that its one-time gene therapy for Duchenne muscular dystrophy had failed to show patient benefits in comparison to a placebo. On...

0January 12, 2021January 12, 2021

QuantumScape

View Complaint Frequently Asked Questions info@portnoylaw.com It is alleged in the complaint that QuantumScape made misleading and/or false statements and/or failed to disclose that QuantumScape’s purported success in relation to its solid-state battery power, battery life, and energy density was overstated significantly and it is unlikely that QuantumScape would be able to scale its technology...

0January 8, 2021January 8, 2021

Triceda

View Complaint Frequently Asked Questions info@portnoylaw.com It is alleged in this complaint that throughout the Class Period, Triceda made misleading and/or false statements and/or failed to disclose that: (i) Tricida’s NDA in regard to veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the NDA for veverimer would not be accepted by the...

0January 8, 2021January 8, 2021